Premium
Midazolam and flumazenil in ophthalmology
Author(s) -
Gobeaux D.,
Sardnal F.
Publication year - 1990
Publication title -
acta anaesthesiologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 107
eISSN - 1399-6576
pISSN - 0001-5172
DOI - 10.1111/j.1399-6576.1990.tb03179.x
Subject(s) - medicine , midazolam , flumazenil , anesthesia , fentanyl , sedation , intraocular pressure , cataract surgery , amnesia , cataracts , ophthalmology , benzodiazepine , receptor , psychiatry
Midazolam's pharmacodynamic properties are used in ophthalmology in several indications: 1. to relieve anxiety and unwanted reactions during radial keratotomy in ambulatory patients; 2. to provide sedation and amnesia during cataract surgery using local anaesthesia, in combination with low doses of phenoperidine; 3. to induce general anaesthesia, combined with fentanyl and vecuronium, for intraocular surgery in the elderly; and 4. to decrease intraocular pressure. Flumazenil is not in routine use but is usually administered to antagonise the deleterious effects of midazolam on upper airway resistances and the respiration system and may be used to reverse “paradoxical”, i.e. anxiogenic reactions to benzodiazepines in the elderly.